UniQure stock tumbles on FDA comments about gene therapy trial
Go back to UniQure stock tumbles on FDA comments about gene therapy trial| UNIQURE (NASDAQ: QURE) | Delayed: 51.15 +3.69 (7.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.46 | 52 Week High | $22.79 | |||
| Open | $48.00 | 52 Week Low | $6.63 | |||
| Day High | $51.72 | P/E | N/A | |||
| Day Low | $47.92 | EPS | $0.00 | |||
| Volume | 1,838,663 | |||||
